Literature DB >> 16782190

Tumour lysis syndrome with acute renal failure during imatinib therapy.

Ridvan Ali, Fahir Ozkalemkas, Atilla Ozkan, Tulay Ozcelik, Vildan Ozkocaman, Ibrahim Akdag, Ulku Ozan, Ahmet Tunali.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16782190     DOI： 10.1016/j.leukres.2006.05.005

Source DB:  PubMed          Journal:  Leuk Res        ISSN： 0145-2126            Impact factor:   3.156


× No keyword cloud information.
  4 in total

1.  Systemic mastocytosis presenting with acute oliguric renal failure: report of a case and review of the literature.

Authors:  Ann E Moore; William H Johnston; Aviv Hever; Susy Peng; Dean A Kujubu
Journal:  Int Urol Nephrol       Date:  2010-11-27       Impact factor: 2.370

2.  Tumor lysis syndrome as a contributory factor to the development of reversible posterior leukoencephalopathy.

Authors:  A Ozkan; B Hakyemez; F Ozkalemkas; R Ali; V Ozkocaman; T Ozcelik; O Taskapilioglu; Y Altundal; A Tunali
Journal:  Neuroradiology       Date:  2006-09-16       Impact factor: 2.804

3.  Estimated glomerular filtration rate changes in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors.

Authors:  Musa Yilmaz; Amit Lahoti; Susan O'Brien; Graciela M Nogueras-González; Jan Burger; Alessandra Ferrajoli; Gautam Borthakur; Farhad Ravandi; Sherry Pierce; Elias Jabbour; Hagop Kantarjian; Jorge E Cortes
Journal:  Cancer       Date:  2015-07-28       Impact factor: 6.860

4.  Therapeutic options for chronic myeloid leukemia: focus on imatinib (Glivec, Gleevectrade mark).

Authors:  Martin Henkes; Heiko van der Kuip; Walter E Aulitzky
Journal:  Ther Clin Risk Manag       Date:  2008-02       Impact factor: 2.423
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.